Global Testing

Tuesday, 17 October 2006

Please see important notice on last page Page 2 of 3

Global Testing

Beefing up management team

Global Testing has announced the appointment of Mr Paul Chien as Chairman

of wholly owned subsidiary GTC Taiwan.

Mr Paul Chien is an industry veteran with more than 25 years experience in the

semiconductor industry. Previously, he was Chairman and President of Vanguard

International Semiconductor Corp., a leading Taiwanese specialty IC foundry

service provider. Under his stewardship as Chairman since Mar 00, Mr Chien

successfully transformed Vanguard from a DRAM company to a primary

specialty IC foundry. Vanguard is a subsidiary of TSMC and is listed on the

Taiwan Stock Exchange.

SINGAPORE

Global Testing (GTC SP)

BUY

Current Price: S$0.24

Target Price: S$0.44

Jonathan Koh

�� (65) 6539 1026

jonathankoh@uobkayhian.com(65) 6539 1026

jonathankoh@uobkayhian.com

Sector Semicon

Bloomberg GTC SP

Reuters

Website

52-Wk Avg Daily Vol. ('000)

Market Cap (S$m)

(US$m)

Book NTA per Share (S$)

ROE (%)

Net Debt per Share (S$)

Results Due

Interim

Final

Regional Morning Notes

Tuesday, 17 October 2006

Page 3 of 3

We have based this document on information obtained from sources we believe to be reliable, but we do not make any representation

or warranty nor accept any responsibility or liability as to its accuracy, completeness or correctness. Expressions of opinion contained

herein are those of UOB Kay Hian Research Pte Ltd only and are subject to change without notice. Any recommendation contained in

this document does not have regard to the specific investment objectives, financial situation and the particular needs of any specific

addressee. This document is for the information of the addressee only and is not to be taken as substitution for the exercise of judgement

by the addressee. This document is not and should not be construed as an offer or a solicitation of an offer to purchase or subscribe or

sell any securities. UOB Kay Hian and its affiliates, their Directors, officers and/or employees may own or have positions in any

securities mentioned herein or any securities related thereto and may from time to time add to or dispose of any such securities. UOB

Kay Hian and its affiliates may act as market maker or have assumed an underwriting position in the securities of companies discussed

herein (or investments related thereto) and may sell them to or buy them from customers on a principal basis and may also perform or

seek to perform investment banking or underwriting services for or relating to those companies.

UOB Kay Hian (U.K.) Limited, a UOB Kay Hian subsidiary which distributes UOB Kay Hian research for only institutional clients,

is an authorised person in the meaning of the Financial Services and Markets Act 2000 and is regulated by The Securities and Futures

Authority.

In the United States of America, this research report is being distributed by UOB Kay Hian (U.S.) Inc (?UOBKHUS?) which accepts

responsibility for the contents. UOBKHUS is a broker-dealer registered with the U.S. Securities and Exchange Commission and is an

affiliate company of UOBKH. Any U.S. person receiving this report who wishes to effect transactions in any securities referred to herein

should contact UOBKHUS, not its affiliate. The information herein has been obtained from, and any opinions herein are based upon

sources believed reliable, but we do not represent that it is accurate or complete and it should not be relied upon as such. All opinions

and estimates herein reflect our judgement on the date of this report and are subject to change without notice. This report is not intended

to be an offer, or the solicitation of any offer, to buy or sell the securities referred to herein. From time to time, the firm preparing this

report or its affiliates or the principals or employees of such firm or its affiliates may have a position in the securities referred to herein

or hold options, warrants or rights with respect thereto or other securities of such issuers and may make a market or otherwise act as

principal In transactions in any of these securities. Any such non-U.S. persons may have purchased securities referred to herein for their

own account in advance of release of this report. Further information on the securities referred to herein may be obtained from

UOBKHUS upon request., a UOB Kay Hian subsidiary which distributes UOB Kay Hian research for only institutional clients,

is an authorised person in the meaning of the Financial Services and Markets Act 2000 and is regulated by The Securities and Futures

Authority.

In the United States of America, this research report is being distributed by UOB Kay Hian (U.S.) Inc (?UOBKHUS?) which accepts

responsibility for the contents. UOBKHUS is a broker-dealer registered with the U.S. Securities and Exchange Commission and is an

affiliate company of UOBKH. Any U.S. person receiving this report who wishes to effect transactions in any securities referred to herein

should contact UOBKHUS, not its affiliate. The information herein has been obtained from, and any opinions herein are based upon

sources believed reliable, but we do not represent that it is accurate or complete and it should not be relied upon as such. All opinions

and estimates herein reflect our judgement on the date of this report and are subject to change without notice. This report is not intended

to be an offer, or the solicitation of any offer, to buy or sell the securities referred to herein. From time to time, the firm preparing this

report or its affiliates or the principals or employees of such firm or its affiliates may have a position in the securities referred to herein

or hold options, warrants or rights with respect thereto or other securities of such issuers and may make a market or otherwise act as

principal In transactions in any of these securities. Any such non-U.S. persons may have purchased securities referred to herein for their

own account in advance of release of this report. Further information on the securities referred to herein may be obtained from

UOBKHUS upon request.

http://research.uobkayhian.com

Global Testing (24 cents) - near complete retracement of rise from 19.5 cent low to 39 cent high causes stock to resume long decline but showing signs of recovery

After 7 weeks of finishing unchanged or lower, the second longest stretch since a year ago when it hit a record 19.5 cent low, the stock edged up last week after appearing to hold up at this year?s 22.5 cent low.

This low was first recorded last July prior to a rebound to the half way mark (29 cents) between 39 cents and 19.5 cents which came about quickly after it managed to move near the 38.2% recovery (27 cents) reaching 26.5 cents about 2 weeks earlier.

Failure to clear 29 cents brought out sellers but after a drop to 25.5 cents, it moved back briefly to 27.5 cents on Sep 6. Since then it was a long road down but somehow the counter managed to hold at 22.5 cents, which was tested for 6 days this month.

This protracted defence of 22.5 cents seemed to assure traders that another rebound to 27-29 cents is on the cards thus lifting the daily lows in the last 3 trading days to 23 and 23.5 cents and to 24 cents today.

Given the near 2 month decline from 29 cents on Aug 17 and the heavy volume of 37.3m shares on Oct 11 when it moved up from 23 cents to 24.5 cents, the stock should be able to break the 24-25 cent resistance and reach 27 cents this month.

Since the May plunge from 39 cents to 27.5 cents, the monthly trading range has been between a minimum 4.5 cents (last month) and 6 cents. So far this month it has moved only 2 cents between 22.5 cents and 24.5 cents.

If it repeats last month?s 4.5 cents range, which should not be a problem since it has just come out from a long 2 month fall, then 27 cents would be the first target and if the trading band widens to 6 cents we should see 28-29 cents.